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ABSTRACT
Here, we show that Escherichia coli Ribonuclease III
cleaves specifically the RNA genome of hepatitis C
virus (HCV) within the first 570 nt with similar effici-
ency within two sequences which are  400 bases
apart in the linear HCV map. Demonstrations include
determination of the specificity of the cleavage sites
at positions C
27 and U
33 in the first (50) motif and G
439
in the second (30) motif, complete competition inhibi-
tion of50 and30 HCVRNA cleavagesbyadded double-
strandedRNAina1:6to1:8weightratio,respectively,
50% reverse competition inhibition of the RNase III
T7 R1.1 mRNA substrate cleavage by HCV RNA
at 1:1 molar ratio, and determination of the 50
phosphate and 30 hydroxyl end groups of the newly
generated termini after cleavage. By comparing the
activity and specificity of the commercial RNase III
enzyme, used in this study, with the natural E.coli
RNase III enzyme, on the natural bacteriophage T7
R1.1 mRNA substrate, we demonstrated that the
HCV cuts fall into the category of specific, secondary
RNase III cleavages. This reaction identifies regions
of unusual RNA structure, and we further showed
that blocking or deletion of one of the two RNase
III-sensitive sequence motifs impeded cleavage
at the other, providing direct evidence that both
sequence motifs, besides being far apart in the
linearRNAsequence,occurinasingleRNAstructural
motif, which encloses the HCV internal ribosome
entry site in a large RNA loop.
INTRODUCTION
The hepatitis C virus (HCV) is a human pathogen causing
chronic liver disease in 170 million people worldwide (1).
The virus is classiﬁed within the family ﬂaviviridae (1).
The RNA genome begins with a 50-untranslated region
(50-UTR) that extends from position 1 to the AUG at position
342, continues in the core (C) coding region which is the ﬁrst
coding locus of a long open reading frame and ends in a
30 non-coding region (1). The secondary structure of the
50-UTR of HCV has been extensively studied since the
early nineties (2,3). Biochemical and functional studies
revealed that the HCV 50-UTR folds into a highly ordered
complex structure with multiple stem loops (2–4) containing
two distinct RNA elements, a short 50-proximal RNA element
(nucleotides 1–43) that regulates HCV replication and trans-
lation (5–7) (domain I) and a longer internal ribosome entry
site (IRES) element, including nucleotides 44–370 and form-
ing domains II, III and IV. Mutational analysis has revealed
that maintenance of the IRES structural domains is critical
for cap-independent initiation of translation of the viral
polyprotein (8–11).
ComparisonofHCV 50-UTR sequences fromdifferent HCV
genotypes has revealed that variation is very limited to par-
ticular sites (12). The sites of genotype variability are usually
covariant substitution sites and they maintain the base paring
required for the 50-UTR secondary structure model (13,14).
There is an interesting exception reported by Honda et al. (15)
in an apparently unpaired region, between positions 21 and
43 where bases A
34 G
35 in genotype 1b correspond to G
34 A
35
in genotype 1a. The presence of A
34 G
35 has been associated
with a 2-fold decrease of the translational efﬁciency in
genotype 1b. This difference was only observed when the
translated fragment contained the region downstream the
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RNA interaction between the region containing the AG dinu-
cleotide preceding the IRES and the capsid coding region
(15). Subsequently, it was observed that mutations introduced
to decrease hypothetical Watson–Crick base pairing between
bases 24–38 and 428–442 could affect levels of IRES-
mediated translation, and that compensatory mutations in
this complementary motif re-established normal levels of
translation directed by HCV IRES (16). Kim et al. proposed
a hypothetical double-stranded RNA (dsRNA) motif whose
duplex stability could regulate IRES activity. Nevertheless,
direct structural proof for these kinds of proposals, derived
from the evolutionary and sequence correlations, is lacking.
RNase III was discovered in 1967 as the third RNase activ-
ity of Escherichia coli (17,18). It was deﬁned as a speciﬁc
dsRNase that cleaved regions of 20 or more base pairs of
RNA–RNA duplex structure and shown to participate in sev-
eral RNA processes, including maturation of rRNA (19,20).
RNase III may also cleave certain other speciﬁc regions with
less perfect base pairings, which invariably contain approxi-
mately two turns of more or less regular dsRNA and additional
sequenceorstructuralelementswhich determine theway these
substrates are cleaved (20). A well-studied example is the
processing of the early mRNA region of the bacteriophage
T7 (21). A set of speciﬁc cleavage reactions carried by E.coli
RNase III enzyme which are favored at high enzyme:substrate
ratios and at lower, rather than higher, monovalent cation
concentration was discovered in 1976 (21). These were
referred to as secondary cleavages; they behave like primary
cleavages in the following way: they are effectively inhibited
by dsRNA competitors for RNase III primarycuts; they are not
inhibited by large molar excess of ssRNA and they are repro-
ducible and speciﬁc, yielding 50 phosphates and 30 hydroxyls
(21). In two well-characterized RNase III substrates, the T7
1.1mRNA (22) (between genes 1.0 and 1.1 of T7 early region)
and a region next to T7 1.2 mRNA (23), primary and sec-
ondary cleavages occur in the opposite side of a hairpin
loop  20 bp long, in a central region where the base pairing
is less regular. Some secondary cleavages, such as that of
R1.2 T7 mRNA, take place in vivo, although only 40% of
the time (24).
Here, we found that two linked RNase III secondary cleav-
age sites ﬂank the HCV IRES of genotype 1b. We also report
that the two cleavages are speciﬁc to E.coli RNase III and
show where the cleavages occur and the category into which
they fall. Special caution was exercised because of using a
commercial RNase III preparation that arises from cleavage of
fusion proteins, toensure that HCV cleavages are not the result
of accompanying RNases or an artiﬁcial broadening of RNase
III speciﬁcity. Finally, we report that the sequences carrying
both cleavage sites interact to construct a single RNase III
signal. This provides a direct proof for the presence of a
structural motif with dsRNA characteristics between a region
immediately preceding the IRES around positions C
27 and
U
33 and a complementary downstream sequence surrounding
positions G
439.
Taken together, the sensitivity of HCV RNA to RNase III
described here represents the structural correlate of previous
functional studies (16) and evolutionary observations (15)
that allow us to conclude that the HCV IRES is embedded
in a larger RNA structure.
MATERIALS AND METHODS
RNase III enzyme
RNase III enzymes were obtained from commercial or natural
sources (18). Commercial Ambion enzyme was the one used
for most of the experiments related to HCV RNA structure.
Commercial enzymes from New England Biolabs and
Epicenter were used as indicated in Results. Natural RNase
III enzyme was obtained from a phosphocellulose column
peak or from a DEAE–Sephadex column peak and was
used to evaluate the speciﬁcity of the commercial Ambion
enzyme under our reaction conditions.
RNA transcripts
The DNA templates for HCV RNA transcripts were derived
from the plasmid vector pN (1–4728) Bluescript, which con-
tains nt 1–4728 of HCV under the T7 promoter. All RNA
transcripts include the ﬁrst base of the HCV genome and
end at positions 402 (Aat-II) S3, 466 (PCR product) S2 and
570 (Blp-I) S1. The PCR product ending at base 466 was
generated by ampliﬁcation of pN (1–4728) with upstream
primer (50-CGCGGATCCTAATACGACTCACTATAGGC-
CGCCCCGATTGGGGGCGA-30 (which serves to introduce
the T7 promoter in the PCR product) and a downstream primer
(50-GGGCCCCTGCGCGGCAACAG-30). The T7 R1.1 RNA
transcript used is a truncated version of the one described
before (25). The RNA product is 60 nt long and contains
the bacteriophage T7 ‘R1.1’ primary and secondary cleavage
sites.
In vitro transcription
To obtain the internally labeled substrates for cleavage assays,
1–2 mg of DNA template were transcribed in vitro (1 h at
37 C) with [a-
32P]GTP followed by a 5 min treatment with
RNase-free DNase I at 37 C. Cellulose CF11 chromatography
was used to eliminate DNA fragments and non-incorporated
nucleotides. Transcripts were then puriﬁed by gel electro-
phoresis under denaturing conditions on 4% polyacrylamide
gels containing 7 M urea. Bands were visualized by auto-
radiography, excised from the gel and eluted in buffer
100 mM Tris–HCl, pH 7.5 and 10 mM EDTA, pH 7.5. The
concentration of radioactive transcripts was determined by
calculating the amount of incorporated [a-
32P]GTP based
on scintillation counting (26).
‘Low speciﬁc activity’ labeled RNA transcripts were made
by scaling up by 40-fold the transcription reaction described
above, and with 1/100 of the concentration of the radioactive
nucleotide.
Obtaining of 50 end-labeled and
30 end-labeled transcripts
Unlabeled ‘cold’ transcripts prepared in standard transcrip-
tion reactions without added radioactive nucleotide label
were subsequently reacted as follows.
30 End labeling. Aliquots containing 40 U T4 RNA ligase and
a molar ratio of 2:1 pmol of 50 [
32P]pCp with respect to RNA
were mixed. The reaction was carried out in 30 mlo f5 0m M
Tris–HCl, pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP,
0.01% BSA and 10% dimethyl sulfoxide, RNasin (20 units)
and T4 RNA ligase (40 units). The reaction mixture was
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using the electrophoretic procedure described above.
50 End labeling. Reactions were carried out using [a-
32P]GTP
and the enzyme guanylyl transferase, and followed the same
puriﬁcation procedure. First, 8 mlo f[ a-
32P]GTP were dried in
aSpeedvac.Meanwhile,thereactionmixture(20ml)contained
50 mM Tris–HCl, pH 8.0, 6 mM KCl, 1.2 mM Mg Cl2,1U
RNasin, 50 nM S-Adenosyl–Methionine (Sigma) and 10 nM
DTT was prepared. Finally, the ‘cold’ RNA transcript is added
to a 2.5 mM ﬁnal concentration. This capping reaction was
initiated by the addition of 1 ml guanylyl transferase (recom-
binant enzyme provided by J. Martinez) and incubated at 37 C
for 4 h. The reaction was stopped by the addition of 2 vol of
loading buffer (0.3% Bromophenol Blue, 0.3% Xilene-cianol,
10 mM EDTA pH, 7.5 and 97.5% desionized formamide)
and the transcript was puriﬁed by denaturing polyacrylamide
gel electrophoresis using the procedure described above.
RNase III cleavage assay: standard
and working conditions
Standard RNase III conditions include a buffer containing
0.01 M Tris–HCl, pH 7.6, 0.13 M NH4Cl and 0.01 M MgCl2.
The salt and buffer conditions used for all of our initial experi-
ments on HCV RNA cleavage by RNase III were the same
used previously to detect RNase P cleavage of a tRNA-like
structure near the AUG start triplet in the HCV IRES. These
are not standard RNase III conditions and are referred in
the text as ‘working conditions’. HCV RNA substrate (0.6 nM
ﬁnal concentration) was pre-heated at 90 C for 1 min, before
the addition of reaction buffer [10 mM HEPES–KOH, pH 7.5,
10 mM Mg(OAc)2 and 100 mM NH4(OAc)] and left to cool
down to room temperature. Cleavage reactions were per-
formed with 20 U RNAsin, and 0.0005 U/ml (ﬁnal concentra-
tion) of E.coli RNase III (Ambion), in the presence of 1 mg/ml
of yeast tRNA, and were carried out at 37 C in a volume of
10 ml for 1 h. These optimal conditions were used in all of the
experiments. Cleavage products were separated on denaturing
polyacrylamide gels and visualized by autoradiography.
Quantitative data relating to RNase III cleavage kinetics
were obtained using a Radioisotopic Image Analyser BAS-
1800 (Fuji ﬁlm). The percentage of uncleaved material was
calculated as the ratio of uncleaved material/starting material.
RNA sequencing with partial nuclease digestion
Partial RNase T1 digestion assays on 50 labeled transcripts.
Aliquots containing 2 · 10
4 Cerenkov c.p.m. of the Cap-50-
LabeledRNA transcriptswere mixed with 2.5mgcarrier tRNA
in 1 mM Tris–HCl (pH 7.5) and 1 mM EDTA (ﬁnal concen-
tration). Cleavage reactions were initiated by the addition of
0.1 mg RNase T1 and incubated at 37 C for 20 min in a ﬁnal
reaction volume of 10 ml.
Nuclease P1 assays on end-labeled transcripts. For RNase
reactions, the digestion mixture (10 ml) contained  2 · 10
4
Cerenkov c.p.m. of the 50 or 30 end-labeled transcript and
2.5 mg of carrier tRNA in 40 mM NH4OAc (pH 5.3),
0.4 mM ZnS04 during 5 min at 70 C. Cleavage reactions
were initiated by the addition of 0.001 mg/ml nuclease P1
(Calbiochem) and incubated at 70 C for 1 min (27).
Alkaline hydrolysis reactions. Aliquots containing 10
4
Cerenkov c.p.m. of end-labeled RNA were incubated with
2 mg of carrier tRNA in 0.2 M NaHCO3–Na2CO3 (pH 9)
and 1 mM EDTA for 5 min at 90 C (27).
All reactions were stopped with 1 vol of loading buffer and
maintained in dry ice until loading in 4% polyacrylamide–
urea sequencing gel.
Circularization assay
The pre-labeled P2 was incubated with T4 RNA ligase using
the same conditions described above (see 30 end-labeled tran-
script), and the reaction was carried out in 10 ml ﬁnal volume.
In a later step, this reaction was treated with 2.5 mg tRNA,
30 mM EDTA, 3% SDS and 0.5 mg proteinase K (previously
pre-heated at 65 C for 1 min) at 65 C for 5 min. After phenol
treatment and precipitation with acetate and ethanol, the
results were visualized on 4% denaturing polyacrylamide gel.
Polynucleotide kinase labeling
The product bands puriﬁed by preparative gel electrophoresis
were labeled using the Kinase Max Kit (Ambion).
Competitive reactions
Competitive inhibition. The experiments consisted of
incubating the same amount of end-labeled HCV transcript
with increasing concentrations of dsRNA (of substantial
length, from a virus grown in Penicillium chrysogenum)
from 2- to 12-fold to inhibit the HCV RNA cleavages. The
conditions for assaying RNase III cleavage are described
above. Poly(I–C) (Sigma) was used for other reactions.
Reverse competitions. The internally labeled transcript
R1.1 is incubated with increasing concentrations (from
1/4- to 4-fold) of cold HCV RNA in the same conditions
described above.
RNA fingerprinting
Oligonucleotides created by RNase T1 digestion of
[a-32P]GTP labeled R1.1 RNA were fractionated to yield
2D ﬁngerprints [ﬁrst dimension by electrophoresis and second
by homocromatography exactly as described previously (28)].
RESULTS
Cleavage of HCV RNA transcripts
Figure 1 is a schematic drawing of the HCV genome, above
which appear the S1,S 2 and S3 transcripts located at the
50-UTR and the ﬁrst one-third of the Core coding region,
all starting at position 1 of the HCV genome. The substrates
are consecutively shortened at their 30 ends (position 570 in S1,
466 in S2 and 402 in S3). Initial E.coli RNase III experiments
involved the S1 substrate transcript, either internally labeled
(Figure 2A), ‘cap’ labeled (Figure 2B) or labeled at its 30 end
(Figure 2C) subsequent experiments utilized the shorter S2
transcript, labeled in the same way (data not shown), allowing
us to distinguish between S1 partial cleavage products P1–P2
and P2–P3 or complete digestion products P1, P2 and P3,
and to position the cleavage sites in the S1 570-base fragment,
5252 Nucleic Acids Research, 2005, Vol. 33, No. 16as shown in Figure 2D. Additional bands that may be seen in
the gel, which are not explored in the present work, are depen-
dent on higher RNase III concentration and may correspond
to less sensitive sites for RNase III.
RNase III is responsible for the HCV RNA cuts
The key experimental question of the HCV RNA cleavages
obtained in the reactions involving commercial RNase III is
whether the cleavages are performed by RNase III itself, rather
than by a co-puriﬁed contaminant activity. The commercial
RNase III used in this study arises by cleavage of fusion
protein and is puriﬁed through various steps with a focus on
dsRNA cleavage, rather than the processing of long ssRNA
with a few speciﬁc sites for cleavage. This leaves open the
possibility of contamination by traces of conventional RNases,
which can cleave ssRNA, or that the recombinant enzyme had
acquired a subtly broadened speciﬁcity. In order to determine
the speciﬁcity of HCV cleavages by RNase III in this work,
two series of experiments were performed: one on the HCV
RNA–RNase III reaction and its cleavage products (classiﬁed
as direct and indirect methods, respectively); the other com-
paring the action of commercial RNase III preparations
and natural E.coli RNase III enzyme puriﬁed by standard
techniques (18,21) on the well-known RNAse III substrate,
bacteriophage T7 R1.1 mRNA.
Direct method: end group determination and
cleavage precision by RNA sequencing
Specific cleavage positions. If RNase III is responsible for
HCV RNA cleavage and if it were to cleave HCV RNA
with the same speciﬁcity as it does other substrates, the site
of cleavage should be between precise nucleotide positions
(23,25,29,30).
Cleavage site within the ﬁrst (50) domain. Non-radioactive
(cold) S1 was 50 end-labeled with [a-
32P]GTP in the presence
of guanylyl transferase and puriﬁed by gel electrophoresis. A
fraction of the labeled RNA was incubated with E.coli RNase
III and another fraction was subjected to partial digestion
with nuclease P1, or to partial hydrolysis with alkali (OH
 ).
RNase III products and partial P1 and OH
  products were
run in parallel on 20% acrylamide gels. Two product bands
appeared in close proximity in the RNase III lane (Figure 3A,
lane 2). In relation to the mobility of the OH
  and P1 partial
products (Figure 3, lanes 3 and 4, respectively), and counting
fromtheﬁrstband,itwaspossibletoconclude thatRNaseIIIis
cleaving the phosphosdiester bond of a percentage of S1 mole-
cules between bases C
27 and C
28 and the rest between bases
U
33 and A
34. The percentage of molecules cleaved at one or
the other position varied between different cleavage reactions,
probably because of small experimental variation (data not
shown).
Cleavage site within the second (30) domain. Because the
RNase III cleavage site in the second (30) domain was appar-
entlytoofarfromtheS130 endtodiscriminateitsexactposition
in a sequencing gel, we prepared a shortened transcript at its
30 end, S2 (see Figure 1). Cold S2 transcript was 30 end labeled
with [a-
32P]pCp and T4 RNA ligase. The downstream RNase
III cleavage product of S2 was named P3* since it is a short-
ened version of product P3. P3* was gel puriﬁed and subjected
to partial digestion with T1 RNase and hydrolysis with OH
 .
The electrophoretic mobility of P3* corresponds to a fragment
with two additional bases (counting from the 30 end of P3*)
than the partial fragment generated by the T1 after cleaving
at position G
441 (see Figure 3B legend and the list of
the T1-resistant oligonucleotides of P3*, Figure 3C and D).
Figure1.OrganizationoftheHCVgenomeandlocalizationofHCVtranscripts
in the viral genome. Relative location of the 50-UTR structural genes (C, Core;
E1 and E2, envelope genes 1 and 2), the p7 coding region and non-structural
genes (NS2 to NS5) and the 30-UTR. S1 (1–570), S2 (1–466), S3 (1–402) have
been used as substrates in the E.coli RNase III assays. All transcripts initiate
atthefirstbaseoftheHCVgenome,containthecomplete50 UTRandexpandto
different sites within the Core-coding region.
Figure 2. Localization of RNase III cleavage sites on HCV transcripts in the
viralgenome.(A–C)AutoradiogramsofE.coliRNaseIIIcleavageofinternally
labeled, 50 end-labeled and 30 end-labeled S1 transcripts, respectively. Lane 1,
the transcript alone incubated on ice; lane 2, transcript incubated in under
‘working conditions’; lane 3, RNase III cleavage reaction. The arrows indicate
the substrate band (S1) and the product bands–partial products (P1–P2) and
(P2–P3)andtotalproducts(P1,P2andP3).(D)Diagramofthecleavagesitesof
HCVRNAbyE.coliRNaseIII.S1 transcript(1–570)isrepresentedwithaline.
RNase III cleavage sites in the positions 27, 33 and 439 respectively, are
indicated by three arrows. Below are represented the final and partial cleavage
productsbandsobservedona4%polyacrylamideelectrophoresisgels,(P1,P10,
P2 and P3) and (P1–P2, P2–P3), respectively.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5253This result located the distal RNase III cleavage between
bases G
439 and A
440.
E.coli RNAse III cleaves perfect dsRNA sequences of low
complexity and many other substrates leaving 2 nt overhands
products. The pattern of cleavage of the duplex at sites 27/439
differs from the general pattern of cleavage of a regular
dsRNA at a given target site. Nevertheless, in cases where
secondary RNAse III cleavage sites have been mapped, as in
the R1.1 and R1.3 T7 RNA substrates, cleavages may produce
a variety of extremes.
Biochemical characterization. One of the distinctive proper-
ties of RNase III is that it releases cleavage products contain-
ing 50 PO4 and 30OH end groups (23,31). Contaminating
RNases almost invariably cleave to yield 50 hydroxyl and
20,3 0 phosphate end groups, and very few RNases cleave
the phosphodiester backbone through the same mechanism
used by RNase III (32,33). To identify the end group of
the reaction products we carried out two different kinds of
experiments. One was an enzymatic approach; the other,
based on electrophoretic mobility.
Enzymatic approach. T4 RNA ligase may add a [a-
32P]pCp
nucleotide to the 30 OH end of an RNA fragment, and also may
circularize terminal RNA fragments ending with a 50 P and
a3 0 OH. On the other hand, T4 polynucleotide kinase can
introduce a
32P from [g-
32P]ATP into the 50 end of an RNA
fragment only if that end already has a 50 OH, or has been
previously dephosphorylated by treatment with a phosphatase.
From all total and partial cleavage products generated after
RNase III cleavage of S1, P2 has the two newly generated
termini. Thus, efforts were ﬁrst concentratedon the determina-
tion of the end groups of P2. Thus, S1 was labeled at low
speciﬁc radioactivity (enough to trace its electrophoretic
mobility but low enough to permit an increase of incorporated
radioactivity in the subsequent end-labeling reactions with
the RNA ligase or polynucleotide kinase). Product band P2
was puriﬁed from other S1 cleavage products after electro-
phoresis, and the recovered radioactivity was divided into
Figure 3. DeterminationofthecleavagesitesintheHCVtranscript.(A)Todeterminethecleavagesitesnearthe50 end,a‘Cap’labeledS1wasprepared.Lane1,S1
RNA transcriptaloneincubatedon ice; lane2, S1 incubatedwith RNaseIII(see conditionsin Figure2).Arrowsindicatethe mostprominentbands(P1, P10); lane3,
alkaline hydrolysis reaction; lane 4, S1 RNase P1 reaction; lane 5, RNA molecular weight markers composed of transcripts with a length of 21, 40, 69, 76, 77, 109
and 135 nt; lane 6, S1 incubated under ‘working’ conditions buffer without enzyme. Samples were electrophoresed on a 20% denaturing polyacrylamide gel. The
RNase III cleavage products (with expected 30 OH end groups) run between two alkaline hydrolysis products (mixtures of RNA fragments with 30P and 20P end
groups), and have been numbered according to the band running faster. Further experiments based on fingerprinting of internally labeled RNA are in progress to
confirmthecleavagepositionpresentedhere.(B)Fordeterminationofthecleavagesitenearthe30 end,theS2(1–465)transcriptwaslabeledwith
32pCpatits30 end
withtheT4RNAligase,cleavedwithRNaseIII,andthemost30-proximalproductP3*(indicatedbyanarrow)gelpurifiedona20%denaturingpolyacrylamidegel.
Lane1,S2transcriptonice;lane2,S2treatedwithRNaseIII(standardconditions);lane3and4,partialhydrolysisofP3*withOH
 afterincubationsof4and8min,
respectively; lane 5, P3* alone; lanes 6 and 7, partial digestions with nuclease T1 at 0.01 and 0.02 mg/ml final concentrations, respectively. The product bands
of RNase T1 identified as A, B, C, D, E, at the left of the electrophoresis gel are described in (D). (C) Representation of the 30 end RNA sequence of S2 containing
the P3* fragment. RNase T1 cleavages after every G-residue are marked. A gap of 8 nt between the B and C product bands in the gel could be clearly positioned
betweenpositionsU
442andG
450,thelargestRNaseT1digestionproductoftheP3*fragment.Thisgapservesasareferencetolocalizethecleavagesitetwopositions
upstream, between bases G439 and A440.
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labeledatits30 endbyT4RNAligaseand[a-
32P]pCp,asshown
by an increase in the label in the autoradiogram in the lane
representing the starting material (Figure 4A, lane 2) as com-
pared with that subsequently treated by the ligase (Figure 4B,
lane1),demonstratinga30OHend;(ii)labeledinthe50endwith
T4polynucleotidekinaseand[g-
32P]ATPpreferentiallywhenit
was previously dephosphorylated by treatment with alkaline
phosphatase enzyme (Figure 4B, lane 1) compared with
whenitwasnot(Figure4B,lane2),demonstratingthepresence
of a phosphate group in its 50 end; (iii) circularized when incu-
batedwithT4RNAligase.Intheelectrophoresisautoradiogram
(Figure4C),itwaspossibletoobserveamoreslowlymigrating
band (lane 2) in relation to untreated material (lane 1) that cor-
responds to circularized P2, proving in a single reaction the
speciﬁc chemistry of RNase III reﬂected in both end groups
at once.
The end-labeling or circularizing experiments described
above were also performed on total and partial digestion frag-
ments of S1 (data not shown) proving the appropriate chemical
groups: speciﬁcally, RNA ligase was able to label the 30 end
of P1, P2 and P1–P2. Dephosphorylation-dependent kinas-
ing was demonstrated in P2 and P2–P3. Circularization was
also demonstrated in P2–P3, but failed as expected in P1–P2,
because of the presence of a 50 pppG in P1 (pppG is not a
substrate for RNA ligase).
Electrophoretic mobility. This second approach was based
on the different electrophoretic motilities of RNA molecules
depending on the nature of the chemical end group. Alkaline
hydrolysis releases products with 50 OH and a 20–30 cyclic
phosphate ends, while nuclease P1 releases products with
changed polarity: 50 PO4 and 30 OH (27). Electrophoretic
mobility of the products from P1 digestion labeled at their
50 ends were compared, in sequencing gels, with the mobility
of a product ladder generated by partial digestion of S1 sub-
strate with alkali or with P1 nuclease. The arrows on the left
of Figure 4D indicate the position of the two 50 S1 products
(see S1cleavage schemeinFigure1); the mobility isparallel to
P1 nuclease products (lane 3), in agreement with the hypo-
thesis that RNase III cleavage has occurred, producing
50 phosphate end groups. Only the end-groups of the shortest
products of the RNase III treatment of HCV IRES substrates,
P1 and P1*, could be tested in this kind of analysis, which is
limited by the resolution of the sequencing gels.
Indirect methods: competitive and reverse
competitive inhibition
Two additional strategies were used to demonstrate that
RNase III, and not a contaminant in the enzyme preparation,
was responsible for the processing reaction in S1 and S2 sub-
strates. All competition reactions, direct and reverse, were
performed in the presence of an excess high amount (2 mg)
of unlabeled tRNA per reaction, which is a large excess over
the competitor RNAs involved in the reaction, and eliminates
the effects of non-speciﬁc inhibition by increasing the total
amount of RNA in the reaction.
(i) Competitive inhibition. This experiment consisted of
incubating the same amount of labeled HCV RNA S1
with increasing concentrations of cold natural dsRNA
(from 2-to12-foldexcess)toinhibitHCV RNAcleavages.
‘Cap’ labeled or 30 end-labeled HCV S1 RNAs were used,
respectively, as appropriate to follow the P1 or P3 short
productfragmentsin14%and20%polyacrylamidegels.As
RNA competitor we employed a dsRNA of substantial
length from a virus grown in Penicillium chrysogenum
(PC RNA) which is a known substrate for E.coli RNase
III (30,31). When this unlabeled (cold) dsRNA, from 20
to120ng,wasincludedintheRNaseIIIcleavage reactions
of ‘cap’ labeled and 30 labeled S1, the amounts of HCV
cleavage products were decreased with increased compe-
titor concentration and reached total inhibition at a weight
ratio of 1 to 6 PC RNA/HCV RNA for the 50 end cleavage
(Figure 5A, lane 6) and 1 to 8 for the 30 end cleavage
(Figure 5B, lane 7). Similar results were obtained using
S2 as a substrate for both sites (data not shown).
(ii) Reverse competition. In competition experiments recipro-
caltothoseshowninFigure5,wetestedtheabilityofS1to
compete for RNase III activity with a 60-base RNA frag-
ment of the natural substrate, phage T7 early precursor
mRNA R1.1 (24,25). This fragment was internally labeled
with[a
32P]GTPduringtranscriptionfromasyntheticDNA
template and was used as a substrate for the in vitro RNase
III cleavage reactions that were competed by increasing
concentrations of cold HCV S1 RNA, from 0.45 to
7.2 nM. About 50% inhibition was reached at a concentra-
tionratioof1HCVRNA/T7R1.1RNA(Figure5C,lane7).
Reversecompetitionexperimentswerealsoperformedwith
S2 as RNA competitor and we obtained the same results
(data not shown).
Figure 4. Biochemical characterization of HCV RNase III cleavage product
end-groups. S1 was internally labeled at low specific radioactivity and cleaved
with RNase III. P2 purified from the gel was subjected to different specific
enzymaticreactionstodeterminechemicalgroupsofthe(A):30 end.Lane1,P2
labeled with [
32P]pCp and T4 RNA ligase; lane 2, P2 alone; lane 3, control
bandsresultingfromastandardreactionofRNaseIIIonS1.( B)5 0 End.Lane1,
P2centralproductbandlabeledwithT4polynucleotidekinaseand[g-
32P]ATP
after treatment with alkaline phosphatase; lane 2, P2 was identically treated as
beforewithoutpriorincubationwithalkalinephosphatase;lane3,P2untreated.
(C)3 0 and 50 ends by P2 product circularization: lane 1, P2 alone; lane 2, P2
circularization with T4 RNA ligase. The band that corresponds to circularized
P2 migrates more slowly than the starting material; lane3, standard RNase III
reaction. (D) Coincident mobility of the 50-terminal RNase III and nuclease P1
cleavage products of substrate S1 50 Cap labeled S1 incubated with: lane 1,
RNase III (the positions of the products P1 (27 nt) and P10 (33 nt) are indicated
by arrows); lane 2, OH
  hydrolysis; lane 3, nuclease P1 treatment.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5255Characterizing the activity of commercial RNase III
versus authentic E.coli RNase III on T7 R1.1 mRNA,
deﬁning the HCV cleavages as secondary
type (19,21)
While performing the reverse competition experiments
described above, we found that commercial RNAse III from
Ambion, in the buffer and salt conditions used to cleave HCV
RNA, cleaved the T7 R1.1 RNA producing four migrating
bands (Figure 5C), instead of two bands as expected from a
single primary cleavage event. Because a secondary cleavage
site has also been described in T7 R1.1 (22) we wanted to
distinguish if, with the Ambion enzyme preparation and in our
salt conditions, we were dealing with the reported secondary
RNase III cleavage type, on the one hand; or an ssRNase-
speciﬁc contaminant in the commercial RNase III preparation
or peculiar behavior of the commercial RNase III preparation,
on the other hand.
A series of experiments were performed to distinguish
among these alternatives. We used the T7 R1.1 RNA substrate
to characterize (i) the activity of the recombinant enzyme from
Ambion, as well as RNase III preparations from two other
companies, in buffer conditions of the standard RNase III
reaction and in comparison with natural E.coli enzyme;
(ii) the activity of the Ambion enzyme on R1.1 RNA substrate
in the buffer and salt conditions used in this paper, taking also
as reference the authentic RNase III preparation; and (iii) the
secondary cleavage site of the Ambion enzyme in R1.1.
(i) Enzymes from Ambion, Epicenter, New England Biolabs
and the natural E.coli RNase III were tested against the
R1.1substrate,transcribedinthepresenceof[a-32P]GTP.
Allreactionscontained0.5mlofRNaseIIIenzymes,alarge
excess of carrier tRNA, RNA substrate and the ‘high
salt original RNase III buffer—0.01 M Tris–HCl,
pH 7.6, 0.13 M NH4Cl and 0.01 M MgCl2 (18,25). While
natural RNaseIII enzyme preparations—one froma phos-
phocellulose column peak (18,21) and another from a
DEAE–Sephadex column peak (18,21)—gave two main
product bands (corresponding to bands B and E in
Figure 6—resulting from primary cleavage of R1.1) and
two additional faint bands (corresponding to bands C and
D in Figure 6), all three commercial enzymes, including
that from Ambion, clearly showed four bands (data not
shown). The different pattern was probably due to the
fact that the natural RNase III preparations had much
lower concentrations than the commercial preparations.
This explanation was also supported by the effect of
2 mg of poly(I–C) dsRNA competitive inhibitor on the
reactions, which drastically decreased the activity of the
natural enzyme preparation while only slightly affecting
the reactions of the much more concentrated commercial
enzyme preparations (data not shown). Because the four
bandsappearedwiththeauthenticRNaseIIIpurifiedwith-
out protein fusion techniques in reactions carried out
under high salt conditions, because they arise in the pre-
sence of excess ssRNA and because their production is
inhibited by dsRNA competitor, we can use these results
to validate the specificity of commercial enzyme with
respect to the natural enzyme.
(ii) Several changes were made in the reaction conditions to
confirm the hypothesis of specific secondary RNase III
cleavage in R1.1 RNA. First, Ambion RNase III was
used at dilution 1/10 and 1/100, and was compared with
Figure 5. Competition assays. (A and B) dsRNA competes with and inhibits the RNase III-specific cleavage of HCV RNA. Cleavage by RNase III of S1 transcript
labeled at (A)5 0 end; (B)3 0 end, in the presence of increasing concentrations of competitor dsRNA. (A) Lanes 1 and 2 correspond to 50 end-labeled RNA alone
(incubated on ice) and incubated with buffer, respectively; lane 3, standard reaction with RNase III; lanes 2–9, cleavage reactions using a constant concentration of
S1 (10 ng) and increasing concentrations of dsRNA (20, 40, 60, 80, 100 and 120 ng, respectively). (B) Identical to (A) but using 30 end-labeled S1.( C) Reverse
competition of RNase III cleavage of T7 R1.1 RNA with HCV RNA. A constant amount of a 60 nt fragment of T7 R1.1 RNA (internally labeled) was cleaved in
the presence of increasing concentrations of HCV RNA S1 without label. Lane 1 and 2, RNA T7 R1.1 alone or incubated with buffer, respectively; lane 3, standard
RNase reaction, but with final concentration of RNase III of 0.0001 U/ml; lane 4, standard reaction with RNase III (0.0005 U/ml); lanes 5–9, RNase III cleavage
of a constant concentration of T7 R1.1 RNA (1.8 nM) and increasing concentrations of S1 RNA (0.45, 0.9, 1.8, 3.6 and 7.2 nM respectively); lane 9, inhibition of
T7 R1.1 RNA cleavage with 300 ng of Penicillium chrysogenum dsRNA (positive control).
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second, increasing amounts of competitor were used;
and third, the high salt buffer conditions were replaced
by the buffer and salt conditions used in this work, invol-
ving lower monovalent salt (Figure 6A, 0.05 M versus
0.13M).Itwasobservedthatatthelowerenzyme:substrate
ratio, bands C and D are only faintly present, and they
disappear at once when the dsRNA competitor is added.
Significantly, in lanes 5–2 of Figure 6 this behavior was
mimicked by the authentic RNase III enzyme. It is clear
thatinlane5,thecontrolreactionwithnodsRNA,bandsC
and D are obviously present; they then disappear as the
dsRNA concentration is raised in lanes 4–2. Thus, the
reaction was favored by high enzyme:substrate ratios
and by lower salt conditions and is effectively inhibited
by dsRNA competitors, as expected for a specific
secondary cleavage event (21).
(iii) Fingerprint analysis of the secondary cleavage site of
R1.1 RNA using the Ambion enzyme was located within
thesameT1fragmentproductasthatofthenaturalenzyme
(data not shown).
Cleavage sequences surrounding HCV 50 and 30
cleavages reside in a single RNA structural motif
with double-stranded character
The two sequences surrounding both cleavage sites in HCV
RNA contain a high degree of complementarity. If both
cleavage sites participate in a single RNA motif with
double-stranded characteristics, deletion of one of the two
complementary sequences should also prevent cleavage in
the other. We prepared S3 substrate, which spanned bases
1–402 and lacked the sequence that comprises 30 the cleavable
site (Figure 1). After RNase III incubation, a set of very faint
bands migrating closely together and below the S3 substrate
appearedinthegel electrophoresis,buttheappearanceofthese
bands is not RNase III dependent as their presence was not
affected by incubation with dsRNA. In addition, this 402-base
substrate was unable to compete with T7 R.1.1 RNA cleavage
by RNase III (data not shown). Thus, S3 substrate has lost
the RNA structure that provides sensitivity to RNase III at
the 50-proximal site.
In a second type experiment, a ribo-oligonucleotide
complementary to positions 23–43 (50-rGGAGUCAUGU-
AUGGCGGAGUC-30), within which the 50 cleavage site is
located, was hybridized in excess concentration (15 nM) to
block the hypothetical downstream Watson–Crick bind-
ing region in HCV RNA substrates (0.6 nM) containing the
30 end cleavage site. S1 substrate was pre-heated in the absence
or presence of the ribo-oligonucleotide, buffer added, and the
reactions cooled to 37 C, when the RNase III enzyme was
added. Aliquots were obtained during the time course of the
reaction and run on polyacrylamide gels. In Figure 7, it may be
observed that in the presence (+) of the complementary ribo-
oligonucleotide the band pattern of the products changed with
respect to those incubated without the ribo-oligonucleotide
( ). Speciﬁcally, a different pattern appeared, consistent with
RNaseIIIcleavage directed solely bytheribo-oligonucleotide.
This proved that blocking the 50 sequence motif impedes the
formation of the RNA structure required for cleavage at the
30 end. Together, the two experiments represent direct proof of
the interaction between sequences containing both cleavages,
enclosing the HCV IRES (Figure 8).
DISCUSSION
Here, we have provided evidence that RNase III from E.coli
cleaves speciﬁcally andwithhighefﬁciencyatsites within two
sequence domains in the HCV IRES, which we have mapped
to one region containing bases 27 and 33, and another region
containing base 439 (Figures 1–3). The ﬁrst region is imme-
diately upstream from the HCV IRES domain, while the other
is  70 bases downstream [assuming that the IRES includes
30ntofsequencedownstreamfromtheAUGstartcodon(34)].
Furthermore, we have conﬁrmed by end group determination
and substrate competition experiments that both natural and
commercial RNase III preparations carry out this reaction
(Figures 4–6). In addition, we have shown by several criteria
that these HCV cleavages by RNase III fall into the category of
speciﬁc secondary cleavages (Figure 6).
Because cleavage within one RNase III-sensitive region of
HCVrequirescoordinatedcleavagewithintheother(Figure7),
we propose that the two widely separated sequence elements
Figure 6. Characterization of commercial RNase III secondary cleaving
activity in comparison to the natural enzyme. Activity of the natural and com-
mercialRNaseIIIinbufferunderworkingconditions(lowersalt).Lane1isthe
R1.1substrateincubated in buffer alone—itrunsas bandA. Lanes2–4,natural
RNase III and R1.1 substrate incubated in the presence of 9, 3 and 1 mg
ofpoly(I–C) dsRNAcompetitor;lane5,controlreactionwithnodsRNA;lanes
6–9allcontainsubstrateand1mlofAmbionRNaseIIIata1/100dilution;lanes
6–8containdecreasingdsRNAcompetitorasinlanes2–4,whilelane9contains
no dsRNA; lanes 10–13 are identical to lanes 6–9,except that they contain 1 ml
of1/10AmbionRNaseIII.Atthelowerenzyme:substrateratio,bandsCandD
areonlyfaintlypresent,andtheydisappearatoncewhenthedsRNAcompetitor
is added.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5257Figure 7. The 50 and 30 cleavages in HCV RNA occur in a single structural motif. Kinetic analysis of E.coli RNAse III cleavage of HCV RNA in the presence or
absenceofacomplementaryRNAoligonucleotide.Leftpanel:autoradiogramofRNaseIIIcleavageofinternallylabeledS1HCVRNAtranscriptinthepresence(+)
or in the absence ( ) of a synthetic RNA oligonucleotide complementary to HCV nt 23–43 (50-GGAGUGAUCUAUGGUGGAGUG-30). HCV RNA substrate
(0.6nMfinalconcentration)waspre-heatedat90 Cfor1min,beforetheadditionofreactionbuffer[10mMHEPES–KOH,pH7.5,10mMMg(OAc)2and100mM
NH4(OAc)]andlefttocooldowntoroomtemperature.Cleavagereactionswereperformedwith20URNAsin,and0.0005U/ml(finalconcentration)ofE.coliRNase
III,inthepresenceof1mg/mlofyeasttRNA,andcarriedoutat37 Cinavolumeof10mlfor1h.Theseoptimalconditionswereusedinalloftheexperiments.In(+)
reactions the synthetic complementary RNA oligonucleotide was added to a final concentration of 15 nM. Lane 13 (‘M’) contains RNA molecular weight markers
composedoftranscriptswithalengthof82,99,110,400and570(S1)nt.Lanesstartingfromtheleftrepresentsequentially10,20,30,40,50and60minofincubation
with RNase III without ( ) or with (+) complementary RNA oligonucleotide. Cleavage products were separated on 4% denaturing polyacrylamide gels and
visualizedbyautoradiography.ThearrowsontheleftindicatetheproductsoftheRNaseIIIcleavagedirectedbythecomplementaryoligonucleotideandontheright;
the products of RNase III alone (P1+P2, P2 and P3) are indicated. Quantitation was performed with a Radioisotopic Image Analyzer. Right panel: Graphic
representation of the time course processing of S1 by E.coli RNAse III in the absence of the complementary RNA oligonucleotide.
Figure 8. Diagram including the proposed structural motif which contains both RNase III cleavage domains and encloses the HCV IRES. On the left is shown the
interactionbetweennt24and38ofthe50 (UTR)withthent428–442oftheHCVCore–codingsequence.ThearrowsrepresenttheRNaseIIIcleavagesites.The‘loop’
is shown within a box on the right of the figure. Symbol ‘P’ refers to the cleavage position of human RNase P, which is another RNA structure dependent nuclease.
After the annealing, both RNase III and RNase P cleavage sites became in close proximity.
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(Figure 8), which is present at sufﬁcient frequency to allow
over 80% of the substrate to undergo RNase III cleavage
(Figure 7). This conclusion is supported by the fact that
50-proximal RNase III cleavage fails to occur in the absence
of the 30-proximal sequence (data not shown), and 30 cleavage
is blocked when the 50 cleavable region is hybridized to a
complementary RNA oligonucleotide (Figure 7). We will
brieﬂy address how these ﬁndings relate to other RNase
III-speciﬁc reactions; how the structured element identiﬁed
here relates to previously identiﬁed HCV IRES structures
and how a dsRNA structure bracketing the IRES might
affect HCV gene expression.
E.coli RNase III carries out three principal reactions (19):
the digestion of perfect dsRNA to 15 bp fragments, indepen-
dent of sequence; primary cleavage, usually of imperfectly
base-paired regions which have evolved to play a role in host
rRNA processing; and secondary cleavage, in which imper-
fectly base-paired regions from other RNAs, which resemble
primary RNase III sites, are cleaved. While both dsRNA
digestion and primary cleavage by RNase III are optimized
in higher (>0.1 M monovalent cation) salt and lower
enzyme:substrate conditions, secondary cleavage is favored
at lower salt and higher enzyme:substrate ratios.
Cleavage sites sensitive to RNase III under low salt condi-
tions, such as the ones described here in HCV RNA, have been
reported in earlier studies on RNase III. In particular, RNase
III cleavage of the genomic RNAs of several eukaryotic RNA
viruses, including poliovirus (35), adenovirus (36) and vesi-
cular stomatitis virus (37,38), as well as mammalian rRNA
(36), have been reported. However, these earlier ﬁndings
neither did lead to a general explanation for the presence of
such RNase III sites, nor did they give rise to further research,
in contrast to the situation with prokaryotic RNase III sites.
This lack of follow-up probably took place because mamma-
lian RNase III-like enzymes had not yet been discovered; and
because the earlier eukaryotic RNase III signals were not
mapped to the base their exact RNA structure could not be
ascertained.
Previously identiﬁed RNA structural elements in the HCV
IRES include a pseudoknot just upstream from the AUG
initiator codon (1–4), a UV-crosslinkable tertiary element in
stem–loop II (39), two E-loop structures (40), one in the upper
part of stem–loop II and the other in stem–loop IIId, a domain
which undergoes UV-activated self-cleavage near the top of
stem–loop II (A. J. Lyons and H. D. Robertson, manuscript
submitted) and a tRNA-like element near the AUG start codon
recognized by human RNase P (26,41). While functions have
been suggested for some of these elements (1,26,41) others
still await assignment. The presence of such elements in the
near vicinity of a structural domain capable of undergoing
RNase III cleavage requires further consideration.
First, there are a growingnumber of similarities betweenthe
HCV IRES and the adjacent core protein coding sequence,
especially the ﬁrst 1/3 thereof. Our data show that an RNAse
III-sensitive structure converts the 50-UTR and 1/3 of the core-
coding region into a circular RNA loop, closed by base pairing
as shown in Figure 8. The IRES and core-coding regions, in
addition to sharing a highly structured character (15,42,43),
overlap in several other ways. First, the IRES contains the
ﬁrst 30 bases of the core-coding sequence. Second, sequences
required for HCV IRES cleavage by human RNase P may
include bases at or near the IRES/core-coding junction
(26,41,44). In addition, the IRES and core-coding regions
share a low degree of sequence variation (1,45,46). Together,
these ﬁndings suggest that the two domains in this part of the
HCV genome may have a structural and evolutionary unity,
despite the coding/non-coding discontinuity, an idea which
is strengthened by our ﬁnding that each domain contributes
one of the two required elements which form the RNase
III-sensitive structure whose discovery we report here.
The circular RNA of the hepatitis delta virus (HDV) is also
an RNA circle (closed covalently rather by hydrogen bonds)
which contains highly structured non-coding and coding
regions that are adjacent to each other (47). Furthermore,
the ‘delta antigen’ protein, encoded by HDV RNA, is a nucleic
acid binding protein like the HCV core protein (48). Both
HDV and the HCV IRES region also contain a motif highly
sensitive to UV irradiation in their non-coding regions (39,49).
Both HCV and HDV also infect the liver to provoke consistent
infections (1,48) and could reﬂect the evolution of a common
unit of RNA expression pathogenic to the human liver.
The HCV RNase III signal maps within 79 and 130 bases of
a previously described RNase P signal (44). With regard to
the presence of tRNA-like structure which stimulates RNase P
cleavage in the near vicinity of RNase III cleavage sites, there
are several noteworthy examples where these two kinds of
signals appear close together, including the E.coli rRNA pre-
cursor molecule, the 10sa RNA molecule, and the mRNA of
several bacteriophages (36,50–53) and in structural RNAs
in yeast (54). The signiﬁcance to in vivo function of both
of these signal types remains to be established for HCV,
although in the other cases mentioned both types participate
in a common RNA processing pathway.
Thepresenceofastructuralelementﬂankingthe HCVIRES
raises questions about how it may affect IRES activity. The
mostdirect role would be inregulating the access of ribosomes
to the IRES start signal. In their study of phylogenetic and
mutational data favoring some type of interaction between
HCV bases 24–38 and 428–442, Kim et al. (16) suggested
that such an element might inhibit translation. Further studies
will be required to measure the ability of IRES-speciﬁc com-
ponents (initiation factors, ribosomal subunits, RNase P) to
bind HCV RNA with versus without the RNase III-sensitive
structure. It is interesting to note, in this regard, that the vast
majority of studies on translation stimulated by the HCV
IRES, both in vitro and in cells and using either mono- or
di-cistronic constructs, have used HCV IRES sequences
spanning only bases 1–400, lacking the RNase III-sensitive
structure. Several studies on ribosome binding and translation
of an HCV mRNA spanning bases 1–1350 (which contains
the RNase III-sensitive structure) are available (55,56), but a
systematic comparison of protein synthesis stimulated by
the same HCV mRNA molecule, with and without the
RNase III-sensitive structure (which can be blocked by cleav-
age or by oligonucleotides, as shown in Figure 7B), is yet to be
performed. Such studies will be necessary to determine
whether the RNase III-sensitive structure promotes or inhibits
ribosome binding and translation, or has no effect.
The 50-UTR of HCV genomic RNA encodes the start signal
for genomic strand RNA synthesis (which is the 30 end of the
antigenomic, or minus, strand), as well as the IRES itself,
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processes. One of the difﬁculties concerning a structure con-
taining the two domains studied here—one near the 50 end
of the HCV UTR involving bases 24–38, the other including
bases 428–442—was that earlier work had suggested a struc-
ture called stem–loop VI within the core-coding domain
(15,43), in which bases 428–442 are base paired with bases
495–508. In fact, the ability of these two potential structures
to alternate could regulate a particular HCV RNA molecule’s
ability to participate in translation versus replication. Experi-
ments comparing the stability of the proposed stem–loop VI
to the RNase III-sensitive structural element studied here will
need to be performed before this idea can be evaluated.
Theconditionsdescribedhereallowreproducible,structure-
dependent cleavagereactionswhich canproducespeciﬁc RNA
fragments for a variety of assays. For example, binding of
translation initiation factors, La protein, PKR and ribosomal
proteins could be conducted before and after RNase III treat-
ment. In this way, both the boundaries of the IRES domain,
and its structural inter-dependence with the ﬂanking, RNase
III-sensitive sequences, can be ascertained. Whatever the role
of the RNase-sensitive structure, it allows new basic studies
on IRES structure and function, and provides opportunities
for RNAi and ribozyme therapeutics as well.
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